Acadian Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-439,767
| Closed | -$1.58M | – | 2183 |
|
|
2019
Q1 | $1.58M | Buy |
439,767
+200,379
| +84% | +$721K | 0.01% | 748 |
|
|
2018
Q4 | $1.47M | Buy |
239,388
+44,642
| +23% | +$274K | 0.01% | 640 |
|
|
2018
Q3 | $1.14M | Buy |
194,746
+80,064
| +70% | +$467K | ﹤0.01% | 692 |
|
|
2018
Q2 | $487K | Buy |
+114,682
| New | +$487K | ﹤0.01% | 898 |
|
|
2017
Q3 | – | Sell |
-156,527
| Closed | -$1.13M | – | 1622 |
|
|
2017
Q2 | $1.13M | Sell |
156,527
-222,669
| -59% | -$1.61M | 0.01% | 681 |
|
|
2017
Q1 | $2.01M | Sell |
379,196
-121,970
| -24% | -$647K | 0.01% | 620 |
|
|
2016
Q4 | $3.6M | Sell |
501,166
-701,561
| -58% | -$5.04M | 0.02% | 472 |
|
|
2016
Q3 | $11.3M | Buy |
+1,202,727
| New | +$11.3M | 0.06% | 254 |
|